Invicorp® Intracavernosal Injection
Invicorp® is licensed for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic or mixed aetiology. In clinical trials, the proportion of Invicorp® injections producing a grade 3 erection was significantly greater than placebo, with a low incidence of pain.
Clinical data is available with respect to clinical efficacy, side effects and patient preference. The cost effectiveness data vs. Caverject® Dual Chamber is available.
